USANA HEALTH SCIENCES INC
NYSE: USNA (USANA Health Sciences, Inc.)
Last update: 13 hours ago15.02
0.19 (1.28%)
| Previous Close | 14.83 |
| Volume | 241,984 |
| Price / Earnings (Forward) | 8.38 |
| Price / Sales | 0.300 |
| Price / Book | 0.520 |
| 52 Weeks Range |
| Profit Margin | 3.98% |
| Operating Margin (TTM) | 6.28% |
| Diluted EPS (TTM) | 1.82 |
| Quarterly Revenue Growth (YOY) | 9.50% |
| Quarterly Earnings Growth (YOY) | -43.10% |
| Total Debt/Equity (MRQ) | 3.94% |
| Current Ratio (MRQ) | 2.05 |
| Operating Cash Flow (TTM) | 58.79 M |
| Levered Free Cash Flow (TTM) | 61.16 M |
| Return on Assets (TTM) | 5.21% |
| Return on Equity (TTM) | 6.42% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Packaged Foods (US) | Mixed | Bearish |
| Packaged Foods (Global) | Bullish | Bearish | |
| Stock | USANA Health Sciences, Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | -2.0 |
| Average | 0.81 |
|
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China). |
|
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| Investment Style | Small Value |
| % Held by Insiders | 42.12% |
| % Held by Institutions | 58.65% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Creative Planning | 30 Jun 2026 | 417,971 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |